# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-020185
Filing Date
2023-04-25
Accepted
2023-04-25 16:02:07
Documents
9
Period of Report
2023-06-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20007145x2_def14a.htm | DEF 14A | 1486901
2 |  | ny20007145x2_barchart01.jpg | GRAPHIC | 100862
3 |  | ny20007145x2_barchart02.jpg | GRAPHIC | 137359
4 |  | ny20007145x2_barchart03.jpg | GRAPHIC | 127458
5 |  | ny20007145x2_pc01.jpg | GRAPHIC | 681059
6 |  | ny20007145x2_pc02.jpg | GRAPHIC | 638417
7 |  | ny20007145x2_piechart01.jpg | GRAPHIC | 91888
8 |  | ny20007145x2_piechart02.jpg | GRAPHIC | 80638
9 |  | ny20007145x2_piechart03.jpg | GRAPHIC | 56918
| Complete submission text file | 0001140361-23-020185.txt |  | 4123237

Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36579 | Film No.: 23844783
SIC: 2836 Biological Products, (No Diagnostic Substances)